DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,461,610 | +12.9% | 308,188 | +9.2% | 0.09% | +18.2% |
| Q2 2023 | $67,732,784 | -4.8% | 282,220 | -0.0% | 0.08% | -6.1% |
| Q1 2023 | $71,157,676 | -9.2% | 282,327 | -4.4% | 0.08% | -11.8% |
| Q4 2022 | $78,396,172 | -65.8% | 295,364 | -66.7% | 0.09% | -68.7% |
| Q3 2022 | $229,247,000 | +182.1% | 887,559 | +176.9% | 0.30% | +197.0% |
| Q2 2022 | $81,267,000 | -12.6% | 320,553 | +1.1% | 0.10% | +5.3% |
| Q1 2022 | $92,991,000 | -21.0% | 317,017 | -11.4% | 0.10% | -17.4% |
| Q4 2021 | $117,783,000 | +16.9% | 357,991 | +8.2% | 0.12% | +6.5% |
| Q3 2021 | $100,724,000 | +46.5% | 330,849 | +29.0% | 0.11% | +45.9% |
| Q2 2021 | $68,773,000 | +43.0% | 256,401 | +20.0% | 0.07% | +27.6% |
| Q1 2021 | $48,090,000 | +19.4% | 213,659 | +17.8% | 0.06% | +9.4% |
| Q4 2020 | $40,286,000 | +2.4% | 181,355 | -0.8% | 0.05% | -15.9% |
| Q3 2020 | $39,357,000 | -11.5% | 182,773 | -27.3% | 0.06% | -18.2% |
| Q2 2020 | $44,466,000 | +15.4% | 251,461 | -9.7% | 0.08% | -11.5% |
| Q1 2020 | $38,543,000 | -12.1% | 278,468 | -2.5% | 0.09% | +16.0% |
| Q4 2019 | $43,854,000 | -20.8% | 285,730 | -25.4% | 0.08% | -27.9% |
| Q3 2019 | $55,342,000 | +54.3% | 383,174 | +52.7% | 0.10% | +52.9% |
| Q2 2019 | $35,874,000 | +7.5% | 251,008 | -0.7% | 0.07% | +3.0% |
| Q1 2019 | $33,362,000 | +1.9% | 252,702 | -20.4% | 0.07% | -15.4% |
| Q4 2018 | $32,725,000 | +21.0% | 317,349 | +27.5% | 0.08% | +56.0% |
| Q3 2018 | $27,038,000 | -14.6% | 248,830 | -22.5% | 0.05% | -24.2% |
| Q2 2018 | $31,675,000 | -5.3% | 320,988 | -6.1% | 0.07% | -14.3% |
| Q1 2018 | $33,460,000 | +8.6% | 341,744 | +3.0% | 0.08% | +5.5% |
| Q4 2017 | $30,805,000 | +29.5% | 331,875 | +19.6% | 0.07% | +19.7% |
| Q3 2017 | $23,795,000 | -16.8% | 277,401 | -18.2% | 0.06% | -19.7% |
| Q2 2017 | $28,611,000 | -9.4% | 339,035 | -8.2% | 0.08% | -13.6% |
| Q1 2017 | $31,582,000 | -3.5% | 369,251 | -12.2% | 0.09% | -9.3% |
| Q4 2016 | $32,732,000 | +76.7% | 420,505 | +77.9% | 0.10% | +76.4% |
| Q3 2016 | $18,524,000 | +16.5% | 236,311 | +50.0% | 0.06% | +10.0% |
| Q2 2016 | $15,906,000 | +42.0% | 157,489 | +33.4% | 0.05% | +38.9% |
| Q1 2016 | $11,199,000 | -25.7% | 118,053 | -27.2% | 0.04% | -7.7% |
| Q4 2015 | $15,067,000 | -6.6% | 162,218 | -14.3% | 0.04% | -17.0% |
| Q3 2015 | $16,137,000 | +12.4% | 189,385 | +12.9% | 0.05% | +27.0% |
| Q2 2015 | $14,354,000 | +5.9% | 167,705 | +5.1% | 0.04% | -7.5% |
| Q1 2015 | $13,549,000 | +16.1% | 159,587 | +17.2% | 0.04% | +2.6% |
| Q4 2014 | $11,671,000 | -25.7% | 136,171 | -34.1% | 0.04% | -37.1% |
| Q3 2014 | $15,708,000 | -20.6% | 206,741 | -17.7% | 0.06% | -24.4% |
| Q2 2014 | $19,774,000 | +54.6% | 251,165 | +47.3% | 0.08% | +46.4% |
| Q1 2014 | $12,791,000 | -47.8% | 170,543 | -46.3% | 0.06% | -52.9% |
| Q4 2013 | $24,519,000 | +38.8% | 317,607 | +24.6% | 0.12% | +24.0% |
| Q3 2013 | $17,666,000 | +19.3% | 254,851 | +8.9% | 0.10% | 0.0% |
| Q2 2013 | $14,811,000 | – | 233,977 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |